Routine CT lung cancer screening of high-risk individuals would save thousands of lives per year for less than a dollar a month per patient if it were implemented throughout the U.S. and would be even cheaper than breast screening.
Small dosage CT screening for lung cancer carried out safely, proficiently and rightfully has become a popular procedure for those diagnosed with Lung Cancer. Drawing knowledge from other screening histories, and from the recent support of the effectiveness of CT screening in a high risk population, it is clear that achieving this goal will require a well-informed public and the commitment of medical professionals to institute best practices. Advances in imaging and biomedical research will continue to evolve rapidly. The breach of CT screening into the healthcare system presents a unique opportunity to develop a coexisting mechanism for collecting data and specimens to accelerate that research and for introducing refinements into the screening process as imaging and biomedical advances occur and is validated.
Given the increasing number of hospitals who study lung cancer, this conference has been developed to provide a forum to all physicians and educators. This multidisciplinary meeting will promote interaction between Medical Oncologists, Radiation Oncologists and Principle Investigators to achieve the best possible outcome for thoracic cancer patients.
Located on the main campus of University Hospitals Case Medical Center in Cleveland, Ohio, UH Seidman Cancer Center opened in spring 2011. The 375,000-square-foot hospital houses all of our cancer services under one roof to optimize patient- and family-centered care, provide the latest therapies, enhance collaboration and promote clinical research and education.
University Hospitals Seidman Cancer Center is part of the Case Comprehensive Cancer Center at Case Western Reserve University, one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers in the nation. With some of the most advanced technology available, dedicated and skilled clinicians, and access to hundreds of clinical trials, UH Seidman Cancer Center is a leading resource in the nation in the fight against cancer, and consistently ranks in the top 20 cancer centers in the country out of more than 5,000 hospitals, according to U.S. News & World Report.
Senior-level executives representing Hospitals, Health Systems, Physician Clinics & Hospital Management Groups:
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter – great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Indi is creating powerful new tools to help physicians diagnose complex diseases with a non-invasive blood test. By measuring multiple biomarkers that serve as sentinels of disease – we are creating tests that help physicians diagnose disease states with greater accuracy.
From developing new therapies that treat and prevent disease to helping people in need, we’re committed to improving health and well-being around the world. Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, consumer care and animal health products. We aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow. Our mission is to discover, develop and provide innovative products and services that save and improve lives around the world.
Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patients’ lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad’s portfolio of molecular diagnostic tests are based on an understanding of the role genes play in human disease and were developed with a commitment to improving an individual’s decision making process for monitoring and treating disease. Myriad is focused on strategic directives to introduce new products, including companion diagnostics, as well as expanding internationally.
Applied Radiology is a board-reviewed clinical journal reaching radiology professionals worldwide in print and digital formats since 1972. Editorially, Applied Radiology covers all aspects of diagnostic radiology, interventional techniques and therapeutic specialties.
AuntMinnie features the latest news and information about medical imaging and is a comprehensive community website for radiologists and related professionals in the medical imaging industry.
AuntMinnie provides a forum for radiologists, business managers, technologists, members of organized medicine, and industry to meet, transact, research, and collaborate on topics within the field of radiology with the ease and speed that only the Internet can provide.
The Caring Ambassadors Lung Cancer Program is a national nonprofit organization devoted to increasing the wellness and longevity of people affected by lung cancer through information, awareness, and interpersonal support. The Caring Ambassadors Program is proud to announce the release of two new resources for people with lung cancer and their loved ones. The 2nd Edition of Lung Cancer Choices and a new publication, Caregiver Choices. Lung Cancer Choices can be a useful tool for anyone who is caring for someone with lung cancer, but its primary focus is on the patient. Caregiver Choices focuses on the unique challenges of caring for someone with lung cancer and provides caregivers with tools and resources for the road ahead. Both publications are available online for free in PDF format.
We are all about lung cancer. We’re about compassion and education. We’re about encouragement and hope. We’re about community. We’re about making the world better for people facing this disease. We’re reaching out and we hope you will take our hand to receive strength from us…or give us strength. Lung cancer is a difficult topic. Most think they know about it. Few do…until they are personally touched by it. Find out more about us, about lung cancer and what you can do to fight it here.
As “The Trusted Resource for Emerging Technology and Clinical Applications in Medical Imaging and Radiation Oncology,” Imaging Technology News (ITN) showcases the latest, most innovative diagnostic & therapeutic technologies and service solutions. ITN is edited for professionals in radiology/medical imaging, therapeutic radiology, business administration and IT in hospitals, freestanding imaging and radiation oncology centers and purchasing organizations. Features include Comparison Charts, Technology Overviews, Advances In, Business & Economics, Case Studies and more.
Since 1990, MOASC has represented more than 400 oncologists in California and neighboring states. Our association has succeeded in providing value to membership through the creation of the MOASC Purchasing Network (MPN), a GPO for purchasing of drugs and medical office supplies; and the MOASC Contracting Network (MCN) created to represent California medical oncologists in developing new contracting and financial relationships with Payors, promote clinical integration, and enhance the quality, and cost effectiveness, of the medical care provided to cancer patients. MOASC is the source of valuable information for their members through their weekly newsletter the California Oncology Weekly, monthly webinars, meetings, certification courses, and practice management consulting. MOASC strives to continue to succeed in ensuring the continued practice of community oncology care, thereby insuring greater access to oncology treatments for the cancer patient.
Phone: 1 800 310 3553 ext. 1
NEWS-Line for HealthCare Providers serves 12 professions nationally via our online, mobile, eNewsletter and magazine formats. On a DAILY basis we update our website with new news items, job opportunities and announcements of conferences and educational opportunities. Each WEEK we summarize these postings with quick eNewsletters tailored to each profession. And MONTHLY or TWICE MONTHLY we collect the best articles and post them in a colorful, reader-oriented, tablet-friendly Magazine format. We also cover 12 Specialty areas in DAILY online and MONTHLY eNewsletter formats. Access and subscriptions to all of our publications and services are completely free to the working or retired professionals, as well as students and faculty members.
Oncology Nurse Advisor (ONA) offers clinical updates and evidence-based guidance to the oncology nurse community online and in print. Daily online articles cover late breaking oncology news, safe handling and administration of chemotherapy drugs, side effect management, and new developments in specific cancers.
ONA also features links to continuing education activities and other resources for nurses and patients, including Q&A sections, the Ask A Pharmacist column, and the ONA Forum, in which oncology nurse experts concisely answer readers’ clinical questions.
Pulmonary Cell News is a free, weekly e-newsletter that keeps members of the pulmonary cell research community informed by providing the latest news from all areas of the field, including science, research and business, to regulatory affairs. Subscribe now to stay current in the latest research news.